The British newspaper, “Daily Mail”, revealed that the US Food and Drug Administration will allow this week to fully vaccinated Americans to receive booster doses different from the vaccine they initially received.
And the newspaper said, this comes after the National Institutes of Health presented data last week showing that recipients of the Johnson vaccine had higher levels of antibodies, as the Johnson booster raised J&J Antibody levels quadrupled over the course of two weeks while booster lift Pfizer Levels 45x, Moderna booster increased Modern Levels 76 times.
The US Food and Drug Administration will allow (FDA) For Americans who have been fully vaccinated with “mix and match” corona vaccines and booster shots.
The Federal Health Agency is expected to approve additional doses for the Moderna and Johnson & Johnson vaccines this week, but officials will also authorize people to get a booster made by a different company than the one that made the vaccine they initially received, according to the New York Times..
This comes after researchers from the National Institutes of Health presented (NIH) Statements at the US Food and Drug Administration Advisory Committee meeting (FDA) It appears that people who received the Corona vaccine from Johnson Johnson & Johnson They had higher levels of antibodies if they got a booster dose of Pfizer Pfizer- BioNTechor moderna Modern.
Previously, the US Food and Drug Administration and the Centers for Disease Control and Prevention warned (CDC) Americans have been mixing and matching shots from any of the three vaccine manufacturers, but attitudes appear to have changed after a new National Institutes of Health report found that people who got the coronavirus vaccine from J & J They have higher levels of antibodies if the booster shot is from a company Pfizer or Moderna.
The report found that when recipients of the Johnson vaccine received J&J With a second dose, their antibody levels quadrupled in two weeks.
By comparison, when they received a Moderna booster, their antibody levels rose 76-fold over the same time period, as did a booster dose of the Pfizer vaccine. Pfizer It also raised antibody levels 45-fold over two weeks – higher than Johnson’s dose J&J , but not as high as Moderna’s dose Modern.